UnknownNot Applicable

Comprehensive Assessment of Risks for Miscarriage.

Bulgaria200 participantsStarted 2020-06-20

Plain-language summary

This study aims to determine the role of serum biomarkers and placental bloodflow in the comprehensive evaluation of the risk for spontaneous abortion

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * visualized fetal structures in utero \& heart pulsations until 8th week of gestation * normal THS/T4 levels * no uterine malformations * BMI \< 27 * signed informed consent Exclusion Criteria: * fetal structures in utero \& heart pulsations not visualized until the 8th week of gestation * elevated THS/T4 levels * uterine malformations * BMI \> 27

What they're measuring

Occurence of a spontaneous abortion

Timeframe: Up to 24 weeks of gestation

Trial details

NCT IDNCT04456660

SponsorOrthogyn Medical Center, Bulgaria

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-20

Contact for this trial

Petar N Ignatov, PhD

0035988896318 ignatov@orthogyn.com

View on ClinicalTrials.gov More Spontaneous Abortion trials